Literature DB >> 4076283

Clostridium difficile colitis in leukemia patients.

G Panichi, A Pantosti, G Gentile, G P Testore, M Venditti, P Martino, P Serra.   

Abstract

Leukemia patients with diarrhea or other abdominal symptoms have been investigated for the presence of Clostridium difficile and its cytotoxin in stools. Of the patients studied 19% had C. difficile, in most cases together with cytotoxin. All patients but one had received antibiotics, while one had been treated with cytotoxic agents only. Symptoms of colitis were most often abdominal pain and distension rather than diarrhea. Owing to the not infrequent fatal evolution, it is recommended that routine search for C. difficile in leukemia patients with abdominal symptoms be performed and appropriate therapy started immediately.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4076283     DOI: 10.1016/0277-5379(85)90008-2

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  6 in total

1.  Superinfections during antimicrobial treatment with betalactam-aminoglycoside combinations in neutropenic patients with hematologic malignancies.

Authors:  P Serra; C Santini; M Venditti; F Mandelli; P Martino
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions.

Authors:  A Pantosti; M Cerquetti; P M Gianfrilli
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

Review 3.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

Review 4.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

5.  Case-control analysis of clostridium difficile-associated diarrhea on a gynecologic oncology service.

Authors:  S E Waggoner; J Barter; G Delgado; W Barnes
Journal:  Infect Dis Obstet Gynecol       Date:  1994

Review 6.  Infections in neutropenic patients I: aetiology.

Authors:  P Engervall; M Björkholm
Journal:  Med Oncol       Date:  1995-12       Impact factor: 3.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.